Moreover, Liu et al. showed that CAP can inhibit IL-6R/pSTAT3 activation to reduce cell proliferation independently of ROS-related pathways in MDA-MB-231 breast cancer cells [10]. This evidence concerns the gene IL6R and breast carcinoma.